Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies
在复发缓解型多发性硬化症患者中,无论是否伴有自身免疫性甲状腺不良事件,使用阿仑单抗治疗6年后生活质量均得到改善:CARE-MS研究的事后分析
期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-020-00191-7
Bertolotto, Antonio; Arroyo, Rafael; Celius, Elisabeth G; Comi, Giancarlo; Havrdova, Eva Kubala; Honeycutt, William David; Hunter, Samuel F; Izquierdo, Guillermo; Kornek, Barbara; Miller, Tamara; Mitsikostas, Dimos D; Singer, Barry A; Ziemssen, Tjalf; Chung, Luke; Daizadeh, Nadia; Afsar, Salman; Hashemi, Lobat; Senior, Peter